Capital Planning Advisors, LLC Eli Lilly & CO Transaction History

Capital Planning Advisors, LLC

$639 Million
Q3 2024

A detailed history of Capital Planning Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Planning Advisors, LLC holds 1,492 shares of LLY stock, worth $1.12 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

1,492

Previous 1,163 28.29%

Holding current value

$1.12 Million

Previous $1.05 Million 25.57%

% of portfolio

0.21%

Previous 0.19%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $254,034 - $315,846	329 Added 28.29%	1,492 $1.32 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $140,624 - $176,353	-194 Reduced 14.3%	1,163 $1.05 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $2,368 - $3,169	-4 Reduced 0.29%	1,357 $1.06 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $29,935 - $35,290	-57 Reduced 4.02%	1,361 $793,000
Q2 2023 Aug 01, 2023	SELL	$350.74 - $468.98 $2,805 - $3,751	-8 Reduced 0.56%	1,418 $665,000
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $3,106 - $3,648	-10 Reduced 0.7%	1,426 $489,000
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $63,666 - $74,184	-198 Reduced 12.12%	1,436 $525,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $192,712 - $219,615	650 Added 66.06%	1,634 $528,000
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $24,528 - $28,799	88 Added 9.82%	984 $319,000
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $1,408 - $1,749	-6 Reduced 0.67%	896 $257,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $202,814 - $251,694	902 New	902 $249,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $991,668 - $1.17 Million	-13,363 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $277,448 - $297,595	3,386 Added 33.94%	13,363 $1.13 Million
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $768,927 - $853,432	9,977	9,977 $853,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning Advisors, LLC with notifications on news.

Account

Capital Planning Advisors, LLC Eli Lilly & CO Transaction History